Levels of CS-846 were significantly higher compared to baseline, whereas levels of AGC were significantly lower in serum of RA patients during 15 month of anti-TNF therapy (p < 0.001 and p < 0.05, respectively; Figure 3a,b). The gene discussed is TNF; the disease is rheumatoid arthritis.